A call to look beyond prescription opioid supply-side restrictions and include health equity when predicting opioid policy effectiveness
Lancet Reg Health Am
.
2021 Sep 10:3:100075.
doi: 10.1016/j.lana.2021.100075.
eCollection 2021 Nov.
Authors
Amie Goodin
1
2
,
Juan M Hincapie-Castillo
3
4
Affiliations
1
Pharmaceutical Outcomes and Policy, University of Florida, USA.
2
Center for Drug Evaluation and Safety, University of Florida, USA.
3
Epidemiology, University of North Carolina Chapel Hill, USA.
4
Injury Prevention Research Center, University of North Carolina Chapel Hill, USA.
PMID:
36777402
PMCID:
PMC9903972
DOI:
10.1016/j.lana.2021.100075
No abstract available